Accueil › Maladie de Crohn › Pennsylvanie › Philadelphia
Essais cliniques pour Maladie de Crohn à Philadelphia, PA
13 études pour Maladie de Crohn recherchent des participants dans et autour de Philadelphia (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Recrutement en coursPhase 3
- Thomas Jefferson University Hospital ( Site 5133), Philadelphia
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Recrutement en coursPhase 2
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 265904, Philadelphia
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Recrutement en coursPhase 3
- Children's Hospital of Philadelphia, Philadelphia
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Recrutement en coursPhase 2/3
- University of Pennsylvania, Philadelphia
- Jefferson Digestive Health Institute, Philadelphia
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Recrutement en coursPhase 3
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Recrutement en coursPhase 3
- University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Recrutement en coursPhase 3
- University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Recrutement en coursPhase 3
- Children's Hospital of Philadelphia (CHOP), Philadelphia
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Recrutement en coursPhase 3
- Children's Hospital of Philadelphia, Philadelphia
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
Recrutement en coursPhase 3
- Children's Hospital of Philadelphia - Main /ID# 262197, Philadelphia
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
Recrutement en coursPhase 4
- Children's Hospital of Philadelphia, Philadelphia
Precise Infliximab Exposure and Pharmacodynamic Control
Recrutement en coursPhase 2/3
- Nemours Children's Health System-Wilmington, Wilmington · à 25 mi
Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
Recrutement en cours
- Children's Hospital of Philadelphia, Philadelphia
Essais pour Maladie de Crohn dans d'autres villes
- New York City, NY35 études
- Boston, MA19 études
- Miami, FL19 études
- Cleveland, OH19 études
- St. Louis, MO19 études
- Tyler, TX17 études
- Orlando, FL17 études
- Houston, TX17 études
- Atlanta, GA17 études
- San Antonio, TX15 études
- San Diego, CA15 études
- Los Angeles, CA15 études
Autres études à Philadelphia
- Cancer (tous types)59 études
- Cancer du sein56 études
- Cancer du poumon non à petites cellules51 études
- Cancer métastatique46 études
- Cancer de la prostate44 études
- Cancer colorectal44 études
- Cancer de l'ovaire44 études
- Cancer du poumon36 études
- Leucémie aiguë myéloïde34 études
- Insuffisance cardiaque31 études
- Cancer de l'endomètre28 études
- Dépression26 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.